Aurora Cannabis (ACB) Free Cash Flow Growth (3y) (2020 - 2025)
Aurora Cannabis (ACB) Free Cash Flow Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 14.41% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 216.31% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.08% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 49.44% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -10.40% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -9.38% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 134.18% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Aurora Cannabis | 243.01 Mn | 170.70 Mn | 25.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 31.15% |
| Mar 31, 2025 | 18.66% |
| Dec 31, 2024 | 165.11% |
| Sep 30, 2024 | 9.80% |
| Jun 30, 2024 | 30.01% |
| Mar 31, 2024 | -0.78% |
| Dec 31, 2023 | 63.81% |
| Sep 30, 2023 | 34.11% |
| Dec 31, 2022 | -154.32% |
| Sep 30, 2022 | -76.26% |
| Jun 30, 2022 | -27.60% |
| Mar 31, 2022 | 6.60% |
| Dec 31, 2021 | 48.65% |
| Sep 30, 2021 | -106.39% |
| Jun 30, 2021 | 34.33% |
| Mar 31, 2021 | -68.99% |
| Dec 31, 2020 | -54.44% |
| Sep 30, 2020 | -95.10% |